Affiliation:
1. Laboratory Department of Fujian Medical University, No. 156 North Xi-er Huan Road, Fuzhou City, Fujian Province, Fuzhou 350025, China
Abstract
Sepsis is still a severe health problem worldwide with high morbidity and mortality. Blood
bacterial culture remains the gold standard for the detection of pathogenic bacteria in bloodstream infections,
but it is time-consuming, and both the sophisticated equipment and well-trained personnel are
required. Immunoassays and genetic diagnosis are expensive and limited to specificity and sensitivity.
Aptamers are single-stranded deoxyribonucleic acid (ssDNA) and ribonucleic acid (RNA) oligonucleotide
or peptide sequence generated in vitro based on the binding affinity of aptamer-target by a process
known as Systematic Evolution of Ligands by Exponential Enrichment (SELEX). By taking several
advantages over monoclonal antibodies and other conventional small-molecule therapeutics, such as
high specificity and affinity, negligible batch-to-batch variation, flexible modification and production,
thermal stability, low immunogenicity and lack of toxicity, aptamers are presently becoming promising
novel diagnostic and therapeutic agents. This review describes the prospective application of aptamerbased
laboratory diagnostic assays and therapeutics for pathogenic bacteria and toxins in bloodstream
infections.
Funder
Science Project Funding of Fujian Province of China
Key Project Funding on Social Development of Fujian Province of China
Natural Science Foundation of Fujian Province
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmacology,General Medicine
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献